EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieVergleichsstudie

Pharmacokinetic and bioequivalence study of apremilast tablets in healthy Chinese subjects under fasting and fed conditions

Pan Lu, Fang Yao, Jie Wang, Yingxia He, Jun Liang, Xuejia Zhai, Guan Liu

Int. Journal of Clinical Pharmacology and Therapeutics · 01.09.2026 · 64 (09) · 487-497

DOI: 10.5414/cp204869 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Int. Journal of Clinical Pharmacology and Therapeutics, erschienen am 01.09.2026. Verfasst von Pan Lu und 6 weiteren Autor:innen. Hauptthemen laut MEDLINE: Thalidomide, Fasting, Phosphodiesterase 4 Inhibitors, Anti-Inflammatory Agents, Non-Steroidal.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ThalidomideFastingPhosphodiesterase 4 InhibitorsAnti-Inflammatory Agents, Non-SteroidalHumansTherapeutic EquivalencyMaleCross-Over StudiesAdultTabletsFemaleYoung AdultArea Under CurveAdministration, OralHealthy VolunteersBiological AvailabilityChinaEast Asian People

Substanzen

apremilastThalidomideTabletsPhosphodiesterase 4 InhibitorsAnti-Inflammatory Agents, Non-Steroidal

Zitieren

APA

Lu, P., Yao, F., Wang, J., He, Y., Liang, J., Zhai, X., & Liu, G. (2026). Pharmacokinetic and bioequivalence study of apremilast tablets in healthy Chinese subjects under fasting and fed conditions. Int. Journal of Clinical Pharmacology and Therapeutics, 64(09), 487-497. https://doi.org/10.5414/cp204869

Vancouver

Lu P, Yao F, Wang J, He Y, Liang J, Zhai X, et al. Pharmacokinetic and bioequivalence study of apremilast tablets in healthy Chinese subjects under fasting and fed conditions. Int. Journal of Clinical Pharmacology and Therapeutics. 2026;64(09):487-497. doi:10.5414/cp204869

BibTeX
@article{Lu2026,
  author = {Lu, Pan and Yao, Fang and Wang, Jie and He, Yingxia and Liang, Jun and Zhai, Xuejia and Liu, Guan},
  title = {Pharmacokinetic and bioequivalence study of apremilast tablets in healthy Chinese subjects under fasting and fed conditions},
  journal = {Int. Journal of Clinical Pharmacology and Therapeutics},
  year = {2026},
  volume = {64},
  number = {09},
  pages = {487--497},
  doi = {10.5414/cp204869}
}
Kostenlos starten →